Xilio Therapeutics, Inc. (XLO)
8.30
-0.05
(-0.60%)
USD |
NASDAQ |
May 27, 16:00
8.30
0.00 (0.00%)
After-Hours: 17:39
Xilio Therapeutics Free Cash Flow : -57.36M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Verastem, Inc. | -160.57M |
| Opus Genetics, Inc. | -38.99M |
| Sensei Biotherapeutics, Inc. | -22.40M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.34M |
| Cash from Investing (Quarterly) | -0.556M |
| Cash from Financing (Quarterly) | 35.71M |
| Free Cash Flow Per Share (Quarterly) | -1.401 |
| Free Cash Flow to Equity (Quarterly) | -22.58M |
| Free Cash Flow to Firm (Quarterly) | -22.90M |
| Free Cash Flow Yield | -59.64% |